Vincenzo Marigliano
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Vincenzo Marigliano has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
A. Bellomo
Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, Sapienza University of Rome, Umberto I, Policlinico di Roma, Viale del Policlinico 155, I-00161 Roma, Italy
3 shared publications- Evaristo Ettorre
Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Division of Gerontology, Sapienza University, Rome, Italy
3 shared publications - Chiara Fossati
Department of Movement, Human and Health Sciences, University of Rome “Foro Italico”, 00135 Rome, Italy
2 shared publications - G. De Benedetto
Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences “Sapienza” University of Rome, Umberto I, Policlinico di Roma. Viale del Policlinico 155, I-00161 Roma, Italy
2 shared publications - Giovanni Troisi
Department of Cardiovascular, Respiratory, Nephrologic, Anesthesiologic and Geriatric Sciences, Sapienza University of Rome, Viale del Policlinico 155, 00161 Roma RM, Italy
2 shared publications M. Mancinella
Department of Cardiovascular, Respiratory, Nephrological and Geriatric Sciences, “Sapienza” University of Rome, Umberto I, Policlinico di Roma, Viale del Policlinico 155, I-00161 Roma, Italy
2 shared publications
Latest Publications
- 1 April 2014
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 28 (2) , 194-197
Olfactory Deficit and Hippocampal Volume Loss for Early Diagnosis of Alzheimer Disease
Background: The aim of this pilot study was to verify the role of olfactory test and volumetric magnetic resonance imaging measure of hippocampus to predict conversion from mild cognitive impairment to Alzheimer disease (AD). Materials and Methods: Eighteen patients with amnesic mild cognitive impairment, broadly defined, were followed at 12 months. Hypothesized baseline predictors for follow-up conversion to AD were olfactory deficit and hippocampal volumes loss. Results: In the 1-year follow-up, 5 patients converted to AD. The 2 clinical predictors olfactory test and hippocampal volume loss showed the same sensitivity of 92.3% but the olfactory test showed a higher specificity than the hippocampal volume loss (75% vs. 60%). Conclusions: Our findings suggest the potential utility of olfactory test and hippocampal volume loss for early detection of AD.
- 1 April 2014
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 28 (2) , 194-197
Olfactory Deficit and Hippocampal Volume Loss for Early Diagnosis of Alzheimer Disease
Background: The aim of this pilot study was to verify the role of olfactory test and volumetric magnetic resonance imaging measure of hippocampus to predict conversion from mild cognitive impairment to Alzheimer disease (AD). Materials and Methods: Eighteen patients with amnesic mild cognitive impairment, broadly defined, were followed at 12 months. Hypothesized baseline predictors for follow-up conversion to AD were olfactory deficit and hippocampal volumes loss. Results: In the 1-year follow-up, 5 patients converted to AD. The 2 clinical predictors olfactory test and hippocampal volume loss showed the same sensitivity of 92.3% but the olfactory test showed a higher specificity than the hippocampal volume loss (75% vs. 60%). Conclusions: Our findings suggest the potential utility of olfactory test and hippocampal volume loss for early detection of AD.
- 1 September 2012
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 55 (2) , 247-250
Atrial fibrillation (AF) and cognitive impairment in the elderly: A case–control study
- 1 September 2012
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 55 (2) , 247-250
Atrial fibrillation (AF) and cognitive impairment in the elderly: A case–control study
- 15 November 2011
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 56 (1) , 27-31
A self-administered questionnaire to screen the risk of dementia: A pilot study and the results of a comparison with the mini-mental state examination (MMSE)
- 15 November 2011
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 56 (1) , 27-31
A self-administered questionnaire to screen the risk of dementia: A pilot study and the results of a comparison with the mini-mental state examination (MMSE)
- 31 December 2007
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 44, 61-67
Diabetes and metabolic syndrome (MS)
- 31 December 2007
- Published by Elsevier in Archives of Gerontology and Geriatrics
- Vol. 44, 61-67
Diabetes and metabolic syndrome (MS)
- 1 September 2000
- Vol. 91 (9) , 450-4
[Rehabilitation in Alzheimer's dementia].
Alzheimer's disease is a neurodegenerative disease that causes a progressive decline of cognitive and behavioural functions. The simultaneous presence of these disorders requires a treatment not only for cognitive decline, but also for behavioural symptoms, depression and caregiver's stress. Research has made many efforts to develop a wide range of treatments, different from current pharmacological therapy, which is not resolutive, owing to the absence of an exact etiopathogenetic mechanism. Since new drugs have not been shown to be really effective in slowing cognitive impairment, various forms of rehabilitative interventions have been proposed in order to treat Alzheimer's disease. Their efficacy in the improvement of cognitive functions is still not completely clear. Surely, interesting results have been obtained from studies about Reality Orientation Therapy, Occupational Therapy and Memory Training. Music therapy might provide a new form of rehabilitative intervention, especially acting on the reducing of behavioural symptoms. These alternative forms of non pharmacological treatment may have a positive effect on caregiver. The heavy emotional burden of seeing a loved one becoming confused and isolated and of having to accept new responsibilities, may be reduced by rehabilitative supports, complementary to the pharmacological therapy. Caregiver stress could be reduced in two ways: by promoting the hope that something is being done for the patient and providing free time for himself.
- 1 September 2000
- Vol. 91 (9) , 450-4
[Rehabilitation in Alzheimer's dementia].
Alzheimer's disease is a neurodegenerative disease that causes a progressive decline of cognitive and behavioural functions. The simultaneous presence of these disorders requires a treatment not only for cognitive decline, but also for behavioural symptoms, depression and caregiver's stress. Research has made many efforts to develop a wide range of treatments, different from current pharmacological therapy, which is not resolutive, owing to the absence of an exact etiopathogenetic mechanism. Since new drugs have not been shown to be really effective in slowing cognitive impairment, various forms of rehabilitative interventions have been proposed in order to treat Alzheimer's disease. Their efficacy in the improvement of cognitive functions is still not completely clear. Surely, interesting results have been obtained from studies about Reality Orientation Therapy, Occupational Therapy and Memory Training. Music therapy might provide a new form of rehabilitative intervention, especially acting on the reducing of behavioural symptoms. These alternative forms of non pharmacological treatment may have a positive effect on caregiver. The heavy emotional burden of seeing a loved one becoming confused and isolated and of having to accept new responsibilities, may be reduced by rehabilitative supports, complementary to the pharmacological therapy. Caregiver stress could be reduced in two ways: by promoting the hope that something is being done for the patient and providing free time for himself.